Proposed labeling rule
FDA targets 278 trade association groups, consumer interest groups and physician groups for comments on proposed labeling rule in an April 16 mailing. "We want to reach out to people who might not be aware through normal channels of the existence of this rule," Center for Drug Evaluation & Research Associate Director for Policy Jane Axelrad said April 18
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth